Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/20/2009

ities is enhanced by this disclosure. In addition, the Company refers to these non-GAAP financial measures with its analysis of the Company's financial performance. These non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.

About Amylin

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information on Amylin Pharmaceuticals is available at www.amylin.com.

This press release contains forward-looking statements about Amylin, which involve risks and uncertainties. Our actual results could differ materially from those discussed herein due to a number of risks and uncertainties, including risks that BYETTA or SYMLIN may be affected by competition, unexpected new data, safety and technical issues, or manufacturing and supply issues; risks that our financial results may fluctuate significantly from period to period and may not meet market expectations; risks that any financial guidance we provide may not be accurate; risks that our clinical trials will not be completed when planned, may not replicate previous results or achieve desired end-points; risks that our preclinical studies may not be predictive; risks that our NDAs for product candidates, such as the exenatide once weekly NDA, or sNDAs for label expansion requests may not be submitted timely or receive FDA approval;
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014   Plexus Information Systems, Inc. ... Information Management Systems (AIMS), announced a partnership with ... wholly owned subsidiary of Quality Systems, Inc. and ... connectivity solutions.  Logo - ... This partnership extends the NextGen Healthcare ...
(Date:10/1/2014)... NOTTINGHAM, England , Oct. 1, 2014  Columbia ... that its subsidiary, Molecular Profiles Ltd., is set to ... annual CPhI/ICSE Worldwide event in Paris ... the rapid development of both standard and complex drug ... which incorporates the company,s existing formulation and analytical development ...
(Date:10/1/2014)... ANTWERP, Belgium and NEW YORK , ... global Contract Research Organization (CRO) and service provider for the medical ... the opening of offices in New York City ... New York City is strategically centered in one of ... the East Coast", said Philippe Kassab , President at genae ...
Breaking Medicine Technology:Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3genae Opens Offices in New York City 2
... Published in The Lancet of Fast-Tracked Antiplatelet Agent Showed ... was Well Tolerated When Given With Standard Platelet TherapyKENILWORTH, ... (NYSE: SGP ) Phase II trial of ... were published today in The Lancet and ...
... uses quantitative imaging endpoints from MRI analysesROCHESTER, N.Y., ... VSCP ), a leading provider of quantitative imaging ... a Canadian medical device company based in Laval, ... Canadian-European pivotal clinical trial for its cartilage repair ...
Cached Medicine Technology:Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 2Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 3Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 4Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 5Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 6Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 7VirtualScopics' Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial 2VirtualScopics' Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial 3
(Date:10/2/2014)... There has been a boom in ... resulted in an increase in the number of web ... at very affordable prices. A leading review website, Best ... hosting companies and announced that InMotion is one of ... buy hosting products. , InMotion ( http://www.best-cheap-hosting-usa.com/go/InMotion/ ) has ...
(Date:10/2/2014)... The Business Intelligence Group today announced ... Business program. The BIG Awards specialize in recognizing ... process scored by well-known and experienced leaders and ... this year epitomize what is going right with ... Business Intelligence Group. “The sheer amount of innovation ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. ... neurotic personality style and prolonged stress may have a ... Tracking 800 women over nearly four decades, Swedish ... and moody -- which they defined as neurotic -- ... developing Alzheimer,s compared to women scoring lowest in these ...
(Date:10/2/2014)... Steven Reinberg HealthDay Reporter ... a major highway may raise your risk for high blood ... postmenopausal women, those who lived within 109 yards of a ... high blood pressure than women living at least half a ... study highlight the importance of our physical environment on our ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. ... of Columbia now have a total of 500 confirmed cases ... infecting children since the summer, U.S. health officials reported ... in recent weeks, but it,s not clear what role -- ... said. Health officials are also trying to determine if ...
Breaking Medicine News(10 mins):Health News:Innovation Dominant Theme among 2014 Big Awards for Business Winners and Finalists 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 3Health News:Living Near a Highway May Be Bad for Your Blood Pressure 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 3Health News:42 States Reporting Respiratory Virus That Targets Kids 2Health News:42 States Reporting Respiratory Virus That Targets Kids 3
... HealthDay Reporter , FRIDAY, Feb. 10 (HealthDay News) -- ... new strain of flu first appeared in Mexico, then spread ... of the globe. The H1N1 "swine" flu strain didn,t ... to children and younger adults -- the very groups of ...
... Excessive consumption of phosphate is damaging to health. Therefore, ... recommended by Eberhard Ritz and coauthors in their article ... [Dtsch Arztebl Int 2012; (109 (4): 49-55]. ... subject, which documents the fact that ex-cessive phosphate consumption ...
... used new tools they developed to analyze knees and hips ... state of repair, while hip joints are not. "This ... about and the main treatment strategy probably would need to ... Virginia Kraus, M.D., Ph.D., professor of Rheumatology and Immunology at ...
... throughout the world to treat wounded patients in countries ... 500 U.S. orthopaedic surgeons traveled to Haiti to help ... earthquake on that Caribbean island. And while the effort ... and other orthopaedic injuries associated with earthquakes, not all ...
... (February 10, 2012) In a study to be ... meeting, The Pregnancy Meeting , in Dallas, Texas, researchers ... can be used to diagnose fetal aneuploidies, including Down ... Because of the importance of the clinical data, the ...
... By Alan Mozes HealthDay Reporter , THURSDAY, ... the runway was impressive and so were the red-hot designer ... Truth" Red Dress Collection fashion show, held in New York ... sponsored by the U.S. National Heart, Lung, and Blood Institute, ...
Cached Medicine News:Health News:H1N1 'Swine' Flu Makes a Comeback in Mexico 2Health News:Arthritic knees, but not hips, have robust repair response 2Health News:AAOS focuses on disaster responders, both yesterday's and tomorrow's 2Health News:AAOS focuses on disaster responders, both yesterday's and tomorrow's 3Health News:AAOS focuses on disaster responders, both yesterday's and tomorrow's 4Health News:Study finds massively parallel sequencing can detect fetal aneuploidies, including Down syndrome 2Health News:Strutting the Catwalk in Red, Stars Promote 'The Heart Truth' 2Health News:Strutting the Catwalk in Red, Stars Promote 'The Heart Truth' 3
... the first skull pin to utilize cutting edges instead ... its way into bone the Hifix pin drills a ... improved initial fixation over standard skull pins. The Hifix ... Hifix pins and in the bremer 3D halo crown. ...
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
Endoscopes...
Patented* Design for Endoscopic Shunt Placement. Designed to pass through standard shunt ventricular catheters for optically guided placement....
Medicine Products: